Neogen Corporation (NEOG) - Cash Flow Conversion Efficiency

Latest as of February 2026: 0.011x

Based on the latest financial reports, Neogen Corporation (NEOG) has a cash flow conversion efficiency ratio of 0.011x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($22.70 Million) by net assets ($2.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NEOG equity financing ratio to measure how much of total assets are equity-financed.

Neogen Corporation - Cash Flow Conversion Efficiency Trend (1992–2025)

This chart illustrates how Neogen Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Neogen Corporation earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Neogen Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neogen Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Grindr Inc
NYSE:GRND
39.888x
Kojamo
HE:KOJAMO
-0.003x
Triumph Group Inc
NYSE:TGI
-1.931x
Magnite Inc
NASDAQ:MGNI
-0.132x
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
N/A
Turkiye Kalkinma Bankasi AS
IS:KLNMA
0.134x
Anhui Anke BioTech Group
SHE:300009
0.055x
Sineng Electric Co Ltd
SHE:300827
-0.028x

Annual Cash Flow Conversion Efficiency for Neogen Corporation (1992–2025)

The table below shows the annual cash flow conversion efficiency of Neogen Corporation from 1992 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Neogen Corporation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-05-31 $2.07 Billion $58.24 Million 0.028x +150.72%
2024-05-31 $3.14 Billion $35.26 Million 0.011x -14.32%
2023-05-31 $3.13 Billion $41.03 Million 0.013x -82.93%
2022-05-31 $887.37 Million $68.04 Million 0.077x -20.54%
2021-05-31 $840.38 Million $81.09 Million 0.096x -18.52%
2020-05-31 $725.18 Million $85.88 Million 0.118x +18.33%
2019-05-31 $637.90 Million $63.84 Million 0.100x -18.90%
2018-05-31 $560.17 Million $69.13 Million 0.123x -3.41%
2017-05-31 $471.76 Million $60.27 Million 0.128x +46.15%
2016-05-31 $404.16 Million $35.33 Million 0.087x -29.94%
2015-05-31 $350.96 Million $43.79 Million 0.125x +76.38%
2014-05-31 $306.30 Million $21.67 Million 0.071x -31.21%
2013-05-31 $258.29 Million $26.56 Million 0.103x +1.12%
2012-05-31 $219.05 Million $22.28 Million 0.102x -33.37%
2011-05-31 $188.98 Million $28.84 Million 0.153x -16.54%
2010-05-31 $153.05 Million $27.99 Million 0.183x +114.21%
2009-05-31 $128.68 Million $10.98 Million 0.085x +20.63%
2008-05-31 $111.25 Million $7.87 Million 0.071x -35.94%
2007-05-31 $91.94 Million $10.16 Million 0.110x -42.08%
2006-05-31 $64.55 Million $12.31 Million 0.191x +55.61%
2005-05-31 $54.84 Million $6.72 Million 0.123x +96.74%
2004-05-31 $47.84 Million $2.98 Million 0.062x -61.50%
2003-05-31 $41.40 Million $6.70 Million 0.162x +69.41%
2002-05-31 $35.55 Million $3.40 Million 0.096x +12.29%
2001-05-31 $29.34 Million $2.50 Million 0.085x -53.05%
2000-05-31 $25.80 Million $4.68 Million 0.181x +16.56%
1999-05-31 $23.80 Million $3.70 Million 0.155x +144.59%
1998-05-31 $23.60 Million $1.50 Million 0.064x -41.97%
1997-05-31 $21.00 Million $2.30 Million 0.110x +8.31%
1996-05-31 $8.90 Million $900.00K 0.101x +277.98%
1995-05-31 $8.80 Million $-500.00K -0.057x -125.74%
1994-05-31 $7.70 Million $1.70 Million 0.221x +436.69%
1993-05-31 $6.10 Million $-400.00K -0.066x +40.05%
1992-05-31 $6.40 Million $-700.00K -0.109x --

About Neogen Corporation

NASDAQ:NEOG USA Medical Devices
Market Cap
$2.62 Billion
Market Cap Rank
#6047 Global
#1930 in USA
Share Price
$12.04
Change (1 day)
+4.42%
52-Week Range
$4.68 - $12.04
All Time High
$48.34
About

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne path… Read more